表紙
市場調査レポート

中国の分子診断市場・検査件数の予測

China Molecular Diagnostics Market, Test Volume & Forecast

発行 Renub Research 商品コード 344768
出版日 ページ情報 英文 84 Pages; 55 Figures; 13 Tables
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=105.42円で換算しております。
Back to Top
中国の分子診断市場・検査件数の予測 China Molecular Diagnostics Market, Test Volume & Forecast
出版日: 2015年11月06日 ページ情報: 英文 84 Pages; 55 Figures; 13 Tables
概要

中国において分子診断部門は10億ドル規模の産業であり、年々急速な発展を遂げています。同国の将来の市場において非常に大きな可能性を秘めており、2015年から2019年にかけて、3億件以上の分子診断検査が行われると予測されています。

当レポートでは、中国の分子診断の市場について調査し、市場規模および検査件数の推移と予測、用途別の詳細分析、市場成長の推進因子および課題の分析、主要事業者のプロファイルなどをまとめています。

第1章 エグゼクティブサマリー

第2章 中国の分子診断市場・検査件数の予測

  • 中国の分子診断市場の推移と予測
  • 中国の分子診断検査件数の推移と予測

第3章 中国の分子診断市場・検査件数によるシェアの分析

  • 中国の分子診断市場のシェア:推移と予測
  • 用途別シェアの推移と予測
  • 中国の分子診断の検査件数によるシェア:推移と予測
  • 検査件数能登用途別シェア:推移と予測

第4章 中国の分子診断検査件数の推移と予測:用途別

  • 癌の分子診断検査件数のシェア:推移と予測
  • 癌検査件数の推移と予測
    • 乳癌
    • 直腸癌
    • 前立腺癌
  • 感染症の分子診断検査件数のシェア:推移と予測
  • 感染症検査件数の推移と予測
    • ウイルス検査
    • HPV検査
  • 遺伝子の分子検査件数のシェア:推移と予測
  • 遺伝子検査件数の推移と予測
    • 血液スクリーニング検査
    • HLA検査

第5章 中国の分子診断市場の予測:用途別

  • 癌の分子診断検査市場のシェア:推移と予測
  • 癌検査市場の推移と予測
    • 乳癌
    • 直腸癌
    • 前立腺癌
  • 感染症の分子診断検査市場のシェア:推移と予測
  • 感染症検査市場の推移と予測
    • ウイルス検査
    • HPV検査
  • 遺伝子の分子診断検査市場のシェア:推移と予測
  • 遺伝子検査市場の推移と予測
    • 血液スクリーニング検査
    • HLA検査

第6章 成長推進因子

  • 高品質のヘルスケア製品に対する中流層からの需要の拡大
  • 中国の感染症診断分野の急激な発展

第7章 課題

  • 政府による支援の不足・一般の低い認知度・償還スキームの未整備
  • 技術をもつ人材の不足

第8章 主な民間臨床ラボ・診断サービス企業のプロファイル

  • Zhejiang Di'an Diagnostics Technology Co., Ltd.
  • ADICON Clinical Laboratories (民間)
  • Guangzhou Kingmed Diagnostics Center Co. Ltd.
  • Kindstar Global (民間)
  • BGI-Shenzhen
  • OriGene Technologies
    • 企業概要
    • 製品・サービス

図表

目次

China Molecular Diagnostics is a Billion dollar industry and its growing year on year rapidly. Molecular diagnostics holds immense potential in future of China Diagnostics Sector. It is predicted that China will perform over 300 Million molecular diagnostic tests during the forecasting period 2015 - 2019. Infectious disease and Oncology Testing both have almost equal share in China Molecular Diagnostics Sector. However in further sub-segmenting of molecular diagnostics market share perspective Virology Cancer Test holds the highest market share followed by Colorectal cancer and Breast Cancer Test.

Rising demand from middle class for high quality healthcare products, rapid development in the diagnosis of infectious diseases and increasing number of private hospitals are some of the growth drivers which is fueling this sector. However industry faces some kind of challenges such as shortage of lab technicians, lack of expertise in advanced technology in the local companies etc.

This is the 5th report on Molecular Diagnostics industry published by Renub Research. This report titled “China Molecular Diagnostics Market, Test Volume & Forecast” provides a comprehensive assessment of the fast-evolving, high-growth China Molecular diagnostics market.

This 84 page report with 55 Figures and 13 Tables studies the China Molecular Diagnostic market from 4 view points:

  • 1) Market & Forecast
  • 2) Application Wise Market & Forecast
  • 3) Application Wise Test Volume & Forecast
  • 4) Profiles of Select Private Clinical Labs & Diagnostic Services Companies

DATA SOURCES

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Renub Research team of industry experts.

Primary sources include industry surveys and telephonic interviews with industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 500 paid databases.

Table of Contents

1. Executive Summary

2. China Molecular Diagnostic Market & Test Volume Forecast

  • 2.1. China Molecular Diagnostic Market (2010-2019)
  • 2.2. China Molecular Diagnostic Test Volume (2010-2019)

3. China Molecular Diagnostic Market & Test Volume Share Analysis

  • 3.1. China Molecular Diagnostic Market Share (2010-2019)
  • 3.2. China Molecular Diagnostic Application Market Share (2010-2019)
  • 3.3. China Molecular Diagnostic Test Volume Share (2010-2019)
  • 3.4. China Molecular Diagnostic Test Volume Application Share (2010-2019)

4. China Molecular Diagnostic Test Volume-Application Wise (2010-2019)

  • 4.1. China Molecular Oncology Test Volume Share (2010-2019)
  • 4.2. Oncology Test Volume (2010-2019)
    • 4.2.1. Breast Cancer Test Volume (2010-2019)
    • 4.2.2. Colorectal Cancer Test Volume (2010-2019)
    • 4.2.3. Prostate Cancer Test Volume (2010-2019)
  • 4.3. China Molecular Infectious Disease Test Volume Share (2010-2019)
  • 4.4. Infectious Disease Test Volume (2010-2019)
    • 4.4.1. Virology Test Volume (2010-2019)
    • 4.4.2. HPV Test Volume (2010-2019)
  • 4.5. China Molecular Genetic Test Volume Share (2010-2019)
  • 4.6. Genetic Test Volume (2010-2019)
    • 4.6.1. Blood Screening Test Volume (2010-2019)
    • 4.6.2. HLA Test Volume (2010-2019)

5. China Molecular Diagnostic Market & Forecast-Application Wise (2010-2019)

  • 5.1. China Molecular Oncology Test Market Share (2010-2019)
  • 5.2. Oncology Testing Market (2010-2019)
    • 5.2.1. Breast Cancer Testing Market (2010-2019)
    • 5.2.2. Colorectal Cancer Testing Market (2010-2019)
    • 5.2.3. Prostate Cancer Testing Market (2010-2019)
  • 5.3. China Molecular Infectious Disease Test Market Share (2010-2019)
  • 5.4. Infectious Disease Testing Market (2010-2019)
    • 5.4.1. Virology Testing Market (2010-2019)
    • 5.4.2. HPV Testing Market (2010-2019)
  • 5.5. China Molecular Genetic Test Market Share (2010-2019)
  • 5.6. Genetic Testing Market (2010-2019)
    • 5.6.1. Blood Screening Market (2010-2019)
    • 5.6.2. HLA Testing Market (2010-2019)

6. Growth Drivers

  • 6.1. Increasing Demand from Middle Class for High Quality Healthcare Products
  • 6.2. Rapid Development in the Diagnosis of Infectious Diseases in China

7. Challenges

  • 7.1. Lack of Government Support, Public Awareness & Reimbursement Schemes for Molecular Diagnostics test
  • 7.2. Shortage of Skilled Technicians in China

8. Profiles of Select Private Clinical Labs and Diagnostic Services Companies

  • 8.1. Zhejiang Di'an Diagnostics Technology Co., Ltd.
    • 8.1.1. Company Overview
    • 8.1.2. Products and Services Offered by Di'an
  • 8.2. ADICON Clinical Laboratories (Privately held)
    • 8.2.1. Company Overview
    • 8.2.2. Products and Services Offered by ADICON
  • 8.3. Guangzhou Kingmed Diagnostics Center Co. Ltd.
    • 8.3.1. Company Overview
    • 8.3.2. Products and Services Offered by Kingmed
  • 8.4. Kindstar Global (Privately held)
    • 8.4.1. Company Overview
    • 8.4.2. Products and Services Offered by Kindstar
  • 8.5. BGI-Shenzhen
    • 8.5.1. Company Overview
    • 8.5.2. BGI's Innovative Approach
  • 8.6. OriGene Technologies
    • 8.6.1. Company Overview
    • 8.6.2. Products and Services Offered by OriGene

LIST OF FIGURES

  • Table 3-1: China - Molecular Diagnostic Application Market Share (Percent), 2010 - 2014
  • Table 3-2: China - Forecast for Molecular Diagnostic Application Market Share (Percent), 2015 - 2019
  • Table 3-3: China - Molecular Diagnostic Test Volume Application Share (Percent), 2010 - 2014
  • Table 3-4: China - Forecast for Molecular Diagnostic Test Volume Application Share (Percent), 2015 - 2019
  • Table 4-1: China - Molecular Infectious Disease Test Volume Share (Percent), 2010 - 2014
  • Table 4-2: China - Forecast for Molecular Infectious Disease Test Volume Share (Percent), 2015 - 2019.
  • Table 4-3: China - Molecular Genetic Test Volume Share (Percent), 2010 - 2014
  • Table 4-4: China - Forecast for Molecular Genetic Test Volume Share (Percent), 2015 - 2019
  • Table 5-1: China - Molecular Infectious Disease Test Market Share (Percent), 2010 - 2014
  • Table 5-2: China - Forecast for Molecular Infectious Disease Test Market Share (Percent), 2015 - 2019
  • Table 5-3: China - Molecular Genetic Test Market Share (Percent), 2010 - 2014
  • Table 5-4: China - Forecast for Molecular Genetic Test Market Share (Percent), 2015 - 2019
  • Table 6-1: China - Major Diagnostic Reagent R&D and Manufacturing Companies in Infectious Diseases, 2010
Back to Top